Authors' reply to Godman and Gustafsson: "A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing"

Appl Health Econ Health Policy. 2013 Feb;11(1):83-4. doi: 10.1007/s40258-013-0009-1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Drug Costs / standards*
  • Drug Industry / economics*
  • Economics, Pharmaceutical*
  • Humans
  • Reimbursement, Incentive / economics*